China Pharma (CPHI) vs Cumberland Pharmaceuticals (CPIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed China Pharma (CPHI) over the past year, gaining 90.2% versus a loss of 51.8%. Over five years, CPIX leads with a +154.7% price change compared with -99.7% for CPHI. Cumberland Pharmaceuticals is the larger company by market cap ($104.6 million vs $41.3 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPHI | CPIX |
|---|---|---|
| Share price | $0.96 | $6.98 |
| Market cap | $41.30M | $104.58M |
| 1-day change | +12.94% | +1.31% |
| YTD return | -20.66% | +75.38% |
| 1-year return | -51.76% | +90.19% |
| 5-year return | -99.65% | +154.74% |
| Forward P/E | — | 49.86 |
| EPS (TTM) | $-0.42 | $-0.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.19 | $9.28 |
| 52-week low | $0.38 | $1.85 |
| Distance from 52-week high | -95.00% | -24.78% |
| Average volume | 5.81M | 87.71K |
| Shares outstanding | 43.02M | 14.98M |
| Employees | 215 | 88 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cumberland Pharmaceuticals is about 2.5 times larger than China Pharma by market value ($104.58M vs $41.30M).
- CPIX has outperformed CPHI by 141.9 percentage points over the past year.
About China Pharma
CPHI stock →China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China.
Healthcare · Drug Manufacturers - Specialty & Generic · 215 employees
About Cumberland Pharmaceuticals
CPIX stock →Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 88 employees
CPHI vs CPIX FAQ
Which is bigger, China Pharma or Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $104.58M compared with $41.30M for China Pharma (CPHI).
Which stock has performed better over the past year, CPHI or CPIX?
CPIX returned +90.19% over the past 12 months, compared with -51.76% for CPHI (price return, excluding dividends). Past performance does not predict future results.
Are China Pharma and Cumberland Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.